NCT00642954
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,008 public trials
572 recruiting studies
Paraproteinemias trial results
NCT02852837
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beijing, China
- Hangzhou, China
- Shanghai, China
- Suzhou, China
NCT01155583
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT03344328
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy Induced Peripheral Neuropathy, +13 more
- Locations
-
- CHU Clermont-Ferrand Clermont-Ferrand, France
NCT01102426
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- 1107 Tuscaloosa, Alabama, United States
- 1103 Los Angeles, California, United States
- 1105 Jacksonville, Florida, United States
- 1102 New York, United States
NCT02335983
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Research Site Bakersfield, California, United States
- CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
- Research Site Burbank, California, United States
- Providence Saint Joseph Medical Center Burbank, California, United States
NCT04236063
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- University Malaya Kuala Lumpur, Malaysia
NCT01258998
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +82 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00966693
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)
NCT00422799
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States